Title and Organization:
David T. Hutchings, MD, PhD, specializes in geriatric neuropathology and Dementia(s). David is also the founder of Dementia and Alzheimer’s Care, LLC a private practice firm focused on the evaluation, treatment and clinical education of all forms of dementia. David works along with the Alzheimer’s Association on the state and national levels for clinical education to practitioners and caregivers as well as provides guidance to the Alzheimer’s Association. David also is the COO for Spectramed. Previously, he served as the CEO for Stonerise Therapy, which provides transitional care services to patients in West Virginia and southeast Ohio. David is also the founder of Dementia and Alzheimer’s Care, LLC, a private practice firm focused on the evaluation, treatment, and clinical education of all forms of dementia. For nearly two decades, David’s clinical practice and research has led him to be a nationally recognized lecturer and panelist on geriatrics, clinical outcomes, dementia, and neuropathology. He has been published in clinical publications and peer-reviewed journals. In 2013, David developed clinical education articles on Amyotrophic Lateral Sclerosis (ALS) for the CNN network, and, in 2019, he was featured for the entire month of August on News Channel 5 in Nashville discussing Alzheimer’s, other forms of dementia, and current research. David graduated with a bachelor's degree from University of Mississippi, a master’s degree from University of Central Missouri, and a doctorate from Nova Southeastern University with a specialization of geriatric neuropathology. David is a Fellow of the second class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.